Thank you, operator. Good afternoon and thank you for joining SQM's earnings conference call for the third quarter of 2024. This conference call will be recorded and is being webcast live. Our earnings press release and presentation with a summary of the results have been uploaded to our website where you can also find a link to the webcast. Ricardo Ramos, our Chief Executive Officer, will be speaking on the call today. Gerardo Illanes, our Chief Financial Officer; Carlos Diaz, CEO of SQM Salar; Mark Fones, CEO of SQM International Lithium; Felipe Smith, Commercial Vice President of SQM Salar; Pablo Hernandez, Senior Director of Business Strategy and Development of SQM Salar; Pablo Altimiras, CEO of Iodine & Nitrates; and Juan Pablo Bellolio, Commercial Vice President of Iodine and Industrial Chemicals, are also available to answer any questions. Before we begin, I would like to remind you that some statements made during this conference call regarding our business outlook, future economic performance, anticipated profitability, revenues, expenses and other financial items are considered forward-looking statements. Please note that the same cautionary language used in our press release and presentation also applies to this call. And now I will leave you with our Chief Executive Officer, Ricardo Ramos.

Hi, thank you. Good afternoon, everyone and thank you for joining us today. We have published our third quarter 2024 financial results with positive volume growth in almost all our business lines compared to last year. Specialty Plant Nutrition has shown solid dynamics with a market size recovery. Volumes in this business line grew more than 20% year-on-year, increasing our revenues by more than 12% despite lower prices seen during this period. We are positive in the specialty fertilizer market and foresee stable price behavior in the midterm. In Iodine, we have observed a subtle but continued price increase since the beginning of the year. We believe that the strong demand growth and limited supply could lead to slight price increases in the coming quarters. We continue to work hard in several projects that should increase our production efficiency and the seawater pipeline which will enable us to increase capacity is moving on schedule. In Lithium, we are proud that we posted our first revenue coming from Mt. Holland and today begins our first spodumene concentrate bidding event. With this initiative, SQM International Lithium expects to promote fair and more transparent pricing information, enhancing lithium market efficiency. The refinery is under commissioning and is scheduled to start operating in mid-2025. Regarding our lithium sales, we reported sales volumes of more than 51,000 metric tons of lithium products and 18% growth year-on-year, demonstrating a strong demand in the market. As anticipated, prices during the third quarter continued the downward trend with average realized prices 24% lower than the second quarter this year. Although demand continues to grow at a strong pace, mainly driven by strong EV sales growth in China, we continue to see prices pressured by a temporary oversupply which has been decreasing considering the production curtailment announced by other market players. We believe current market prices are far from equilibrium given the fact that demand keeps on growing at a strong pace while current prices are significantly below the incentive price required for projects announced by different players in the market. Our more than 30 years track record in the lithium industry has proved that we have a long-term view in this business and therefore we strongly believe in the lithium market and its fundamentals which are highly related to the clean energy transition that we are experiencing. SQM is in a strong competitive position and well prepared to continue developing our projects in Chile and abroad to harvest the benefits of this transition. Thank you.

We will now start the question and answer session. Our first question is from Joel Jackson with BMO Capital Markets. Please proceed.

Hi, good morning, Ricardo and team. I'll ask a few questions. So my first question would be, you know, you call out in your prepared materials about the industry having some curtailments. You've maintained your own sales guidance for the year at 190,000 to 195,000 tons. Pricing is still going down. Does SQM need to cut share here? Cut volume to help support the market? Can prices recover if all the players in the industry don't cut volume?

Hello Joel, this is Felipe. Well, indeed this year we are expecting to reach sales volumes close to 195,000 tons and for next year, we're not planning any curtailment, I think you asked for. We are just planning to increase our sales in line with increasing production.

Okay, that's extremely obvious there, direct. Thank you. Okay, the next question I have is, can you talk about what's going on in Australia? So, you're ramping up Mt. Holland spodumene. Did you have any sales in the quarter? It looked like in your released, maybe you did. What's your guidance there? Are you just starting to get close to ramping the conversion plant? Do you feel comfort in the conversion profitability at that project? And you see a lot of competitors taking down Australian capacity. They're cutting spodumene volume. They're cutting conversion capacity in Australia. Might your joint venture have to look at that as well?

Hi Joel, this is Mark Fones here. Yes, we continue, as you mentioned, to ramp up the Mt. Holland project. The concentrator this year is going to produce volumes in the range of around 110,000 to 130,000 tons of spodumene concentrate. That's 5.5% lithium oxide content and that parade continues to ramp up into next year. We've seen monthly production rising steadily over the last few months and we expect that to continue into the future.

Okay, and my final question on that would be considering all the experiences of your competitors, Kwinana, competitor conversion plants in Australia, Kwinana, Cameron, seeing what's happening there, have you thought about the possibility that your conversion plant and the joint venture could be negatively profitable, have startup issues like the rest? And could you consider then if that's the case, what would make you decide to instead toll the spodumene in China to get better profitability?

Let me provide a few points there. First, while the Kwinana refinery is not yet at steady-state production, we continue and are actually tolling today in China. We will remain flexible in that aspect that we choose to sell either spodumene concentrate or lithium hydroxide in this near-term future. Regarding your point about other experiences of our neighbors, I cannot comment on that. I can tell you that we have done from the beginning of the project everything possible to assess all potential issues that could arise in the commissioning and production of the refinery and Kwinana refinery. We have conducted extensive additional engineering, design and workshops to assess those potential issues, so we expect those not to happen for us. Of course, commissioning is a high challenge; it's a risky period of any project. So we remain attentive to any issues that may arise in the future. Regarding the long-term value of the Kwinana refinery and the lithium industry overall, we remain absolutely confident that's why we're doing this project. We believe in the value-added perspective of having a refinery in Australia, and we remain committed to that.

Thank you.

The next question is from Ben Isaacson with Scotiabank. Please go ahead.

Thank you very much and good morning everyone. Just two questions from me. The first question is on the lithium outlook for 2025. Can you just talk about how you see the shape of the market balance developing through the year? When do you see inventory restocking? When do you see new supply coming on or do you expect the market to just kind of grow at a linear pace in 2025?

Hey, Ben. This is Pablo Hernandez. So, from the global lithium demand, we believe it remains strong. Of course, we expect it to surpass over 1.1 million this year and be more than 20% higher than last year. For the remaining of the decade, we expect that lithium demand could reach around 3 million tons and we maintain a forecast of 16% to 18% growth on a yearly basis for the next five years. The main driver of lithium demand growth is the EV market, and the EVs comprise more than 70% of the global lithium demand today. That share could increase to over 80% by the end of this decade. The EV penetration right now is roughly 20% and we expect that to reach 50% by 2030. Out of that demand, China concentrates close to 80% of lithium demand. The EV sales in China could surpass more than 11 million units this year and 17 million globally if you think about EVs in 2024. In terms of global supply, we expect that to continue growing, aligned with demand, with some new projects potentially being disincentivized, those announced by some of our competitors if prices remain at the current levels.

Great, thank you. And my second question is on the Iodine market. Can you just give us a reminder as to the size of the market right now? How is it growing? But more importantly, how much new capacity do you expect to come online in 2025 and 2026? Thank you.

Hi Ben, this is Juan Pablo. We estimate that the market size today is around 38,000 to 39,000 tons of iodine. The growth this year has been especially big due to the decrease of 2023. We expect this year the demand to grow around 7%, driven mainly by the contrast media industry. We expect that that industry will remain growing for the rest of the decade, around 5% to 6% per year. Regarding the new supply, the market information that is available from our competitors shows that we may expect some new supply by the second half of 2025 and some also new supply in 2026. However, we believe that that supply won't be able to catch the increase in demand. So we expect still a strong demand and strong prices in the next couple of years due to that imbalance.

Thank you.

The next question is from Corinne Blanchard with Deutsche Bank. Please go ahead.

Hey, good morning everyone. Two questions. The first one, can you give an update on the agreement with Codelco and how the negotiations are going with the local communities? And the second question is, can you please also explain what's going on with the SEC investigation? I think we saw a note in one of the recent 8-K mentioning that or just wondering what's going on and what could be the potential impact? Thank you.

Hello, this is Ricardo Ramos. Regarding the contract with Codelco, it’s public knowledge that the transaction concludes once all conditions are met. We are putting in a lot of effort to ensure this happens as quickly as possible. Both SQM and Codelco are focused on finalizing the process promptly. The engagement with the communities is progressing as expected, and there are no specific updates regarding the agreement with Codelco. It is moving forward per our expectations, and we aim to finalize everything once all conditions are satisfied. Now, about your second question, Gerardo?

Hi, Corinne, this is Gerardo. The company is required to be in compliance with all applicable laws and regulations in Chile and internationally with respect to anti-corruption, anti-money laundering and other regulatory matters, including the Foreign Corruption Practice Act, FCPA. The company has received a request for information and subpoena from the SEC requesting information related to our Business Operations Compliance Program, allegations of potential violations of the FCPA and other anti-corruption laws. The SEC has said that the investigation is a non-public fact-finding inquiry and we are not aware of any conclusion reached by the SEC. Management has initiated an internal review to identify materials that are responsive to the SEC's inquiry and are actively cooperating in the SEC's review by providing the information requested.

The next question is from Gabriel Simões with Goldman Sachs. Please go ahead.

Hi. Thank you for the presentation. Thanks for taking my questions. I have two actually. So the first one is on volumes. So all of your production keeps tolling and we've seen Mt. Holland starting to ramp up. We still saw slightly lower sales volume quarter-over-quarter. You reiterated your sales volume guidance for the year at 190,000 to 195,000 tons, and this implies a significant reduction in volume throughout the fourth quarter. I just wanted some more color on the dynamics for your sales and to understand what level of production you expect for this year and how we should think about the potential gap between production and sales for the coming years as well? So this is the first question. And on the second question, we saw your lifting costs coming lower than we expected this quarter despite the fact that you are ramping up your operations in Australia. So I just wanted to have more color on how that operation impacts your costs and if you could give us a breakdown of your production cost by geography that would be great as well. Thank you.

Hi Gabriel, this is Carlos Diaz. Let me answer your question regarding the production in SQM Salar, Chile. For DG Ag, we expect the production to be close to 210,000. That means 180,000 is going to be produced at our chemical plant in Antofagasta and the other 30,000 is going to be produced in China in our own plant and machine, plus some tolling agreements that we have with third parties. So this year is going to be close to 210,000. For next year, we are considering producing around 230,000; part of those will be produced - most of those will be produced in our chemical plant in Chile and the remaining part processed in China. Obviously, as Felipe commented before, the sales should be aligned with that increase.

Hi Gabriel, I can comment on Mt. Holland. So as mentioned, Mt. Holland for year 2024 is in the range I mentioned of 110,000 to 130,000 tons of spodumene concentrate, 5.5% lithium oxide content. That's again 100% joint venture, so 50% to each partner. For next year, the guidance is somewhere in a range between 160,000 to 190,000 tons again of spodumene concentrate 5.5%, the full Mt. Holland project.

Gabriel, this is Gerardo. Regarding your question about cost, it's important to consider that within the cost of goods sold line that we report on the financial statements is included the payments that we make to CORFO associated with the lease agreement that we have that lets us access Salar de Atacama. But also keep in mind that this time for the first time, we included sales also coming from Mt. Holland. Approximately 900 tons came from Mt. Holland and those sales are not subject to the lease payments that we make to CORFO. So that probably is affecting your estimates on cost. Regarding production costs in general, we don't have anything special to comment at this moment. As Mark was saying, Mt. Holland is in commissioning, so that is of course having somewhat of an impact on the current cost when compared to the long-term cost.

All right, thank you.

The next question is from César Pérez-Novoa with BTG Pactual. Please go ahead.

Yes, good afternoon, gentlemen. I have two questions. How much did SQM International account for the 51,000 tons of lithium sold in the third quarter? And how much would this represent of the roughly 45,000 to 48,000 metric tons implied for the fourth quarter of 2024? And my second question would relate to iodine. As you mentioned, demand was strong in the third quarter to the level where SQM even had to tap into your own inventory to serve industry demand. Considering the outlook that you portray in the first half of 2025 and the likelihood that competitor supply may be delayed and/or insufficient to meet overall demand, how prepared and equipped is SQM to undertake additional volumes that the market may not provide? Thank you.

Hello, César, this is Mark again. As Gerardo just mentioned, during the third quarter, SQM International lithium sales represented 900 tons of lithium hydroxide. For the current quarter in progress, we expect similar volumes in the range of 1,000 to 1,200 tons of lithium hydroxide. Thanks.

Hello César, Pablo speaking. Yes, as we commented before, the iodine demand this year has been strong. The growth will be 7%. However, next year we see a more moderated growth, close to 2.5%. As we have also commented before, by the second half of next year, we see that initial capacity will come from third parties. Therefore, we believe that our level of sales will be similar compared to what we expect to sell this year. That means that we will use part of our inventories, but we don't see a big effect in the sales that we're going to do next year.

All right, thank you very much.

This concludes our question and answer session. I would like to turn the conference back over to Isabel Bendeck for any closing remarks.

Thank you everyone for joining us. This is the end of the third quarter conference call.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.